Page 183 - Read Online
P. 183

Borzio et al. Hepatoma Res 2019;5:15  I  http://dx.doi.org/10.20517/2394-5079.2019.11                                             Page 11 of 16


               Table 3. Natural history of small hypovascular nodules at MRI and evaluated by gadoxetic acid uptake at hepatic phase
                Author (years)     Type      HE intensity  Nodules   Acquaired   Mean follow-up  Risk factors
                                              at baseline    (n)   hypervascularity  (months)
                Kumada et al. [81] , 2011  Retrospective   Hypo-  49  6 (27%)       12     Size ≥ 15 mm
                Motosugi et al. [80] , 2011 Retrospective   Hypo-  135  16 (12%)           Size ≥ 10 mm
                                                                                           Fat content
                                                                                           enlargement
                Kim et al. [83] , 2012  Retrospective   Hypo-  214    75 (35%)      11     Hyperintensity at DWI
                Hyodo et al. [82] , 2013  Retrospective   Hypo  160   50 (31%)      12     Rapid growth (tumor
                                                                                           volume doubling time
                                                                                           = 542 days)
                                                                                           T2W hyper-intensity
                Higaki et al. [84] , 2014  Retrospective   Hypo  60   10 (17%)      12     Higher growth rate
                Kim et al. [85] , 2016  Retrospective  Hypo  114      26 (23%)      42     T1w hyperintensity
                                              No T2W                                       Size > 10.5 mm
                                              hyperintensity                               Previous HCC
                                                                                           Rapid growth rate
                Sano et al. [86] , 2017  Retrospective  Iso-hyper  663  6 (0.9)     36     Size > 10 mm
               HCC: hepatocellular carcinoma


               In summary, results from imaging-based studies provide evidence showing that indeterminate hypovascular
               nodules may evolve into mature HCC but this transition is hardly predictable based on initial clinical
               characteristics and MR imaging features. The risk and speed of neoplastic evolution of hypovascular nodules
               seems to depend mostly on their behaviour at HE phase on gadoexetic-acid enhanced MRI. Hypo-intense
               nodule at HE phase, have an elevated risk to became hypervascular pHCC in a short interval, whereas
               nodules iso/hyper-intense at HE phase, showed a minimal oncogenic risk [80-86] . Among the numerous risk
               factors found, the growth rate per se seems to have the highest positive predictive value and should be
               regarded as the most reliable alarm ring for radiologic evolution to progressed HCC.



               SURVEILLANCE AND TREATMENT
               The proper follow-up of non-malignant lesions is still debated and, theoretically, it should be dictated by the
               intrinsic risk of neoplastic evolution [Table 4]. Guidelines do not specifically address this issue even though
               a strict follow up is recommended. Once a nodule is histologically classified as dysplastic, either LG-DN
               or HG-DN, it should enter an enhanced follow-up the goal of which is to promptly capture its neoplastic
               transformation. However, indications on such an enhanced surveillance are not uniform among different
               guidelines. An interval of 3-4 months seems to be reasonable since it would ensure that, in case of malignant
               transformation, nodule would not grow beyond curability. For nodule diagnosed only by imaging, the
               interval should be dictated by radiologic characteristics. Hypovascularity coupled with hypo-intensity
               at HE by gadoexetic-acid MRI call for a strict follow up. Conversely, hypovascular nodules showing iso/
               hyperintensity at HE-phase should be monitored by standard six months interval and with a follow-up no
               longer than 3 years. Eighteen months observation period as that recommended by AASLD/EASL guidelines
               seems to be inadequate since neoplastic transformation of some DN may take longer interval. As to which
               imaging technique should be employed, ideally it should be able to detect changes either in size and/or in
               vascular profile. Therefore, a dynamic imaging is preferable to standard ultrasound. CEUS, being cheaper,
               safer and more accessible than CT or MRI seems to be preferable in clinical practice since it can catch
               changes either in size or vascularity. Gadoexetate-enhancing MRI with DWI evaluation remains the recall
               imaging of reference to confirm neoplastic transition of nodules.


               Early treatment of dysplastic nodules, which may theoretically improve survival is controversial. Unlike in
               others human models of gastrointestinal carcinogenesis (colo-rectal and gastroesophageal cancer) where
               treatment of precancerous lesions is recommended, in hepatocarcinogenetic model data supporting this
               policy are still lacking and evidences from the natural history of preneoplastic lesions discourage their
               systematic treatment. Recommendations on this issue by international guidelines are discordant. American
   178   179   180   181   182   183   184   185   186   187   188